Immune privilege or inflammation? Insights into the Fas ligand enigma

被引：132

作者：

O'Connell, J ^{[1
]}

Houston, A

Bennett, MW

O'Sullivan, G

Shanahan, F

机构：

[1] Natl Univ Ireland, Univ Hosp, Dept Med, Cork, Ireland

[2] Natl Univ Ireland, Mercy Hosp, Dept Surg, Cork, Ireland

来源：

NATURE MEDICINE | 2001年 / 7卷 / 03期

基金：

英国惠康基金;

关键词：

D O I：

10.1038/85395

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Fas ligand (FasL) has become an enigmatic molecule: some evidence indicates that it contributes to immune privilege in tissues and tumors, whereas other data demonstrates that FasL can elicit inflammation. New findings may begin to reconcile the paradoxical effects of FasL.

引用

页码：271 / 274

页数：4

共 42 条

[11] Massive acinar cell apoptosis with secondary necrosis, origin of ducts in atrophic lobules and failure to regenerate in cyanohydroxybutene pancreatopathy in rats [J].

Kelly, L ;

Reid, L ;

Walker, NI .

INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 1999, 80 (04) :217-226

[12] Depletion of the natural killer cell population in the peritoneum by AK-5 tumor cells overexpressing Fas-ligand: A mechanism of immune evasion [J].

Khar, A ;

Varalakshmi, C ;

Pardhasaradhi, BVV ;

Ali, AM ;

Kumari, AL .

CELLULAR IMMUNOLOGY, 1998, 189 (02) :85-91

[13]

Kim YS, 2000, ARCH PATHOL LAB MED, V124, P687

[14] Stimulation of CD95 (Fas) blocks T lymphocyte calcium channels through sphingomyelinase and sphingolipids [J].

Lepple-Wienhues, A ;

Belka, C ;

Laun, T ;

Jekle, A ;

Walter, B ;

Wieland, U ;

Welz, M ;

Heil, L ;

Kun, J ;

Busch, G ;

Weller, M ;

Bamberg, M ;

Gulbins, E ;

Lang, F .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (24) :13795-13800

[15] Prolonged survival of rat liver allografts transfected with Fas ligand-expressing plasmid [J].

Li, XK ;

Okuyama, T ;

Tamura, A ;

Enosawa, S ;

Kaneda, Y ;

Takahara, S ;

Funashima, N ;

Yamada, M ;

Amemiya, H ;

Suzuki, S .

TRANSPLANTATION, 1998, 66 (11) :1416-1423

[16] FasL is more frequently expressed in liver metastases of colorectal cancer than in matched primary carcinomas [J].

Mann, B ;

Gratchev, A ;

Böhm, C ;

Hanski, ML ;

Foss, HD ;

Demel, G ;

Trojanek, B ;

Schmidt-Wolf, I ;

Stein, H ;

Riecken, EO ;

Buhr, HJ ;

Hanski, C .

BRITISH JOURNAL OF CANCER, 1999, 79 (7-8) :1262-1269

[17] Induction of antigen-specific immunosuppression by CD95L cDNA-transfected 'killer' dendritic cells [J].

Matsue, H ;

Matsue, K ;

Walters, M ;

Okumura, K ;

Yagita, H ;

Takashima, A .

NATURE MEDICINE, 1999, 5 (08) :930-937

[18] EXPRESSION OF APO-1 (CD95), A MEMBER OF THE NGF/TNF RECEPTOR SUPERFAMILY, IN NORMAL AND NEOPLASTIC COLON EPITHELIUM [J].

MOLLER, P ;

KORETZ, K ;

LEITHAUSER, F ;

BRUDERLEIN, S ;

HENNE, C ;

QUENTMEIER, A ;

KRAMMER, PH .

INTERNATIONAL JOURNAL OF CANCER, 1994, 57 (03) :371-377

[19] Regulation of Fas ligand expression in breast cancer cells by estrogen: functional differences between estradiol and tamoxifen [J].

Mor, G ;

Kohen, F ;

Garcia-Velasco, J ;

Nilsen, J ;

Brown, W ;

Song, J ;

Naftolin, F .

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2000, 73 (05) :185-194

[20]

Mottolese M, 2000, INT J CANCER, V89, P127, DOI 10.1002/(SICI)1097-0215(20000320)89:2<127::AID-IJC5>3.0.CO

← 1 2 3 4 5 →